Driving Global Change: Foundation Medicine’s Leadership in Companion Diagnostics & Impact on Patient Testing
Time: 9:00 am
day: Conference Day 1 AM
Details:
- CDx Leadership: Nearly 60% of approved CDx indications for NGS testing in the US and Japan
- BioPharma Support: Expanding testing options for biopharma partners
- Japan Market Access: Enhancing patient testing and market access • Global Expansion: Insights into our expansion into China and HGRAC experiences
